Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TMS Neuro Solutions provides FDA-cleared transcranial magnetic stimulation (TMS) therapy for patients with major depressive disorder (including treatment-resistant depression), obsessive-compulsive disorder, and anxious depression. TMS therapy is a non-invasive, device-based treatment focused on stimulating brain networks involved in mood regulation and emotional processing. The company’s mission is to reduce reliance on prescription medications for depression by offering an alternative, evidence-based intervention. TMS Neuro Solutions’ treatment devices are used in many leading medical facilities, but clinical outcomes vary and TMS does not guarantee remission for all patients[2]. The company is a provider of clinical services, not a biotech or pharmaceutical developer, and does not manufacture drugs or biologics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TMS Neuro Solutions.